NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-057-2008-0-CH-58 Method for treating uterine fibroids CH EP 13187859.7 Issued
NICHD E-057-2008-0-FR-60 Method for treating uterine fibroids FR EP 13187859.7 Issued
NICHD E-057-2008-0-DE-59 Method for treating uterine fibroids DE EP 13187859.7 Issued
NICHD E-057-2008-0-IE-62 Method for treating uterine fibroids IE EP 13187859.7 Issued
NICHD E-057-2008-0-TW-13 Use Of Ulipristal For Treating Uterine Fibroids TW National Stage 098103314 Issued
NICHD E-057-2008-0-EP-09 Use Of Ulipristal For Treating Uterine Fibroids EP National Stage 09706347.3 Issued
NICHD E-057-2008-0-AU-03 Use of ulipristal for treatment uterine fibroids AU National Stage 2009209652 Issued
NICHD E-057-2008-0-ZA-04 Use Of Ulipristal For Treating Uterine Fibroids ZA National Stage 2010/06049 Issued
NICHD E-057-2008-0-PCT-02 Use Of Ulipristal For Treating Uterine Fibroids PCT PCT PCT/EP2009/050961 Expired
NCI E-043-2009-0-US-01 Development Of A T-Cell Receptor Targeted To The Human Tyrosinase Tumor Antigen US 61/147,846 Abandoned
NCI E-065-2008-0-PCT-02 Association Of The ECHDC1/RNF146 Gene Region On Human Chromosome 6q With Breast Cancer Risk And Protection PCT PCT PCT/US2009/032113 Expired
NICHD E-249-2008-0-US-01 Phantoms For Calibration Of Magnetic Resonance Diffusion Measurements. US 61/147,314 Abandoned
NCI E-250-2007-0-PCT-02 Induced Internalization of Surface Receptors PCT PCT PCT/US2009/031865 Expired
NCI E-250-2007-0-EP-03 Induced Internalization of Surface Receptors EP National Stage 09704018.2 Abandoned
NCI E-078-2006-0-US-06 Cellular Receptor for Antiproliferative Factor US National Stage 12/374,787 Abandoned
NIA E-141-2000-0-US-12 Agents Useful For Reducing Amyloid Precursor Protein And Treating Dementia And Methods of Use Thereof US CON 12/357,115 7786162 Expired PDF
NCI E-077-2008-0-PCT-02 Use Of HPV Virus-like Particles To Deliver Gene-based Vaccines; PCT PCT PCT/US2009/031600 Expired
NHLBI E-062-2006-0-US-05 Thymic Stromal Lymphopoietin Receptor Molecules And Uses Thereof US CON 12/356,534 Expired
NIAID E-050-2008-2-PCT-01 Influenza DNA Vaccination And Methods of Use Thereof PCT PCT COMB PCT/US2009/031329 Expired
NCI E-151-2008-0-US-01 Administration of Radiotherapy by Calculating Internal Organ Motion US 61/145,487 Abandoned
NCI E-094-1994-0-US-05 JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3) US DIV 12/354,668 7902348 Abandoned PDF
NIAID E-323-2005-2-US-03 Vaccines Against Potential Pandemic Strains Of Influenza US DIV 12/354,085 7744901 Abandoned PDF
NCI E-025-2009-0-US-01 Ratio Based Biomarker Of Survival Utilizing PTEN And Phospho-AKT US 61/144,501 Abandoned
NCI E-290-2006-2-JP-04 MICRO-RNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF COLON CANCER-RELATED DISEASES JP National Stage 2009-519525 Abandoned
NCI E-230-2002-2-US-08 Catalytic Domains Of Beta (1,4)-Galactosyltransferase I Having Altered Donor And Acceptor Specificities Domains, That Promote In Vitro Protein Folding And Methods For Their Use US DIV 12/321,006 Abandoned
NCI E-290-2006-2-US-02 METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING MICRORNA-21 US National Stage 12/373,358 8084199 Issued PDF
NCI E-220-2009-3-US-14 Human Immunodeficiency Virus (HIV) Nucleotide Sequences, Recombinant Polypeptides, And Applications Thereof (NAT PATENT RIGHTS) US REISSUE 12/352,068 41158 Expired PDF
NCI E-263-2006-1-US-02 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA US ORD 12/373,191 9464324 Issued PDF
NCI E-225-2008-0-US-01 A Low-Cost, Self-Collection Device ("SELF") For Detection Of Human Papillomavirus(HPV) And Cervical Cancer Screening US 61/204,725 Abandoned
NCATS E-055-2008-3-PCT-01 Substituted 3,6-diphenyl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines As Potent Inhibitors Of PDE4A, PDE4B And PDE4D PCT PCT COMB PCT/US2009/000105 Expired
NCATS E-055-2008-3-US-04 Phosphodiesterase Inhibitors US National Stage 12/812,291 Abandoned
NCATS E-055-2008-3-EP-02 Substituted 3,6-diphenyl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines As Potent Inhibitors Of PDE4A, PDE4B And PDE4D EP National Stage 09701318.9 Abandoned
NCATS E-055-2008-3-IN-03 Substituted 3,6-diphenyl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines As Potent Inhibitors Of PDE4A, PDE4B And PDE4D IN National Stage 4996/DELNP/2010 Abandoned
NCI E-043-2008-0-GB-08 Anti-HIV Domain Antibodies and Methods of Making and Using Same GB EP 09700209.1 Issued
NCI E-043-2008-0-FR-07 Anti-HIV Domain Antibodies and Methods of Making and Using Same FR EP 09700209.1 Issued
NCI E-043-2008-0-DE-06 Anti-HIV Domain Antibodies and Methods of Making and Using Same DE EP 09700209.1 Issued
NCI E-043-2008-0-EP-04 Anti-HIV Domain Antibodies and Methods of Making and Using Same EP National Stage 09700209.1 Issued
NIAID E-285-2002-0-US-13 LUTZOMYIA LONGIPALPIS POLYPEPTIDES AND METHODS OF USE US DIV 12/350,179 8628780 Expired PDF
NCI E-043-2008-0-PCT-02 Anti-HIV Domain Antibodies and Methods of Making and Using Same PCT PCT PCT/US2009/030351 Expired
NIAAA E-092-2006-0-EP-05 Ketone bodies and ketone body esters as blood lipid lowering agents EP National Stage 09701051.6 Issued
NIAAA E-092-2006-0-GB-13 Ketone bodies and ketone body esters as blood lipid lowering agents GB EP 09701051.6 Issued
NIAAA E-092-2006-0-DK-10 Ketone bodies and ketone body esters as blood lipid lowering agents DK EP 09701051.6 Issued
NIAAA E-092-2006-0-FR-12 Ketone bodies and ketone body esters as blood lipid lowering agents FR EP 09701051.6 Issued
NIAAA E-092-2006-0-DE-09 Ketone bodies and ketone body esters as blood lipid lowering agents DE EP 09701051.6 Issued
NIAAA E-092-2006-0-NL-14 Ketone bodies and ketone body esters as blood lipid lowering agents NL EP 09701051.6 Issued
NIAAA E-092-2006-0-SE-15 Ketone bodies and ketone body esters as blood lipid lowering agents SE EP 09701051.6 Issued
NIAAA E-092-2006-0-TR-16 Ketone bodies and ketone body esters as blood lipid lowering agents TR EP 09701051.6 Issued
NIAAA E-092-2006-0-ES-11 Ketone bodies and ketone body esters as blood lipid lowering agents ES EP 09701051.6 Issued
NIAAA E-092-2006-0-BE-08 Ketone bodies and ketone body esters as blood lipid lowering agents BE EP 09701051.6 Issued
NIAAA E-092-2006-0-IN-06 An orally ingestible composition as BLOOD LIPID LOWERING AGENTS IN National Stage 1655/MUMNP/2010 Abandoned